Enhanced cardiovascular diagnostics using wearable ECG and bioimpedance monitoring with LightGBM classifier

IF 10.61 Q3 Biochemistry, Genetics and Molecular Biology
Prince Jain , Ramji Gupta , Anand Joshi , Andrey Kuzmin
{"title":"Enhanced cardiovascular diagnostics using wearable ECG and bioimpedance monitoring with LightGBM classifier","authors":"Prince Jain ,&nbsp;Ramji Gupta ,&nbsp;Anand Joshi ,&nbsp;Andrey Kuzmin","doi":"10.1016/j.biosx.2025.100617","DOIUrl":null,"url":null,"abstract":"<div><div>Cardiovascular diseases (CVDs) are the leading cause of death worldwide, necessitating advanced diagnostic and monitoring tools. Traditional methods of cardiac monitoring face challenges such as limited availability, high costs, and continuous physician oversight. Recent advancements in mobile health (mHealth) technologies, including wearable devices and mobile applications, offer promising solutions for continuous and real-time monitoring of vital signs such as ECG, bioimpedance, and physical activity. This study focuses on integrating these monitoring modalities to enhance the accuracy and reliability of cardiovascular diagnostics. Specifically, we explore the use of the MAX30001 device for precise ECG and bioimpedance measurements in wearable applications. Machine learning techniques, particularly LightGBM, are employed to classify cardiac conditions based on the collected data. The LightGBM classifier achieved a test set accuracy of 94.49 %, with precision, recall, and F1-scores above 0.95 for all classes. The model's performance was further validated through cross-validation (CV), yielding a 5-fold CV accuracy of 95.86 % and a 10-fold CV accuracy of 96.16 %. The ROC curve analysis showed excellent discriminatory ability with AUC values close to 1. These findings highlight the potential applications of advanced mHealth solutions in providing continuous, accurate, and real-time monitoring of cardiovascular health, which can lead to better patient management and outcomes through timely and informed interventions.</div></div>","PeriodicalId":260,"journal":{"name":"Biosensors and Bioelectronics: X","volume":"24 ","pages":"Article 100617"},"PeriodicalIF":10.6100,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biosensors and Bioelectronics: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590137025000445","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Cardiovascular diseases (CVDs) are the leading cause of death worldwide, necessitating advanced diagnostic and monitoring tools. Traditional methods of cardiac monitoring face challenges such as limited availability, high costs, and continuous physician oversight. Recent advancements in mobile health (mHealth) technologies, including wearable devices and mobile applications, offer promising solutions for continuous and real-time monitoring of vital signs such as ECG, bioimpedance, and physical activity. This study focuses on integrating these monitoring modalities to enhance the accuracy and reliability of cardiovascular diagnostics. Specifically, we explore the use of the MAX30001 device for precise ECG and bioimpedance measurements in wearable applications. Machine learning techniques, particularly LightGBM, are employed to classify cardiac conditions based on the collected data. The LightGBM classifier achieved a test set accuracy of 94.49 %, with precision, recall, and F1-scores above 0.95 for all classes. The model's performance was further validated through cross-validation (CV), yielding a 5-fold CV accuracy of 95.86 % and a 10-fold CV accuracy of 96.16 %. The ROC curve analysis showed excellent discriminatory ability with AUC values close to 1. These findings highlight the potential applications of advanced mHealth solutions in providing continuous, accurate, and real-time monitoring of cardiovascular health, which can lead to better patient management and outcomes through timely and informed interventions.
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biosensors and Bioelectronics: X
Biosensors and Bioelectronics: X Biochemistry, Genetics and Molecular Biology-Biophysics
CiteScore
4.60
自引率
0.00%
发文量
166
审稿时长
54 days
期刊介绍: Biosensors and Bioelectronics: X, an open-access companion journal of Biosensors and Bioelectronics, boasts a 2020 Impact Factor of 10.61 (Journal Citation Reports, Clarivate Analytics 2021). Offering authors the opportunity to share their innovative work freely and globally, Biosensors and Bioelectronics: X aims to be a timely and permanent source of information. The journal publishes original research papers, review articles, communications, editorial highlights, perspectives, opinions, and commentaries at the intersection of technological advancements and high-impact applications. Manuscripts submitted to Biosensors and Bioelectronics: X are assessed based on originality and innovation in technology development or applications, aligning with the journal's goal to cater to a broad audience interested in this dynamic field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信